Drugs Made In America Acq... (DMIIU)
NasdaqGM: DMIIU
· Precio en tiempo real · USD
10.17
-0.01 (-0.10%)
Al cierre: Aug 12, 2026, 10:47 AM
Drugs Made In America Acquisition II Corp. (DMIIU) Stock Price, Analysis & Data
-0.10% (1D)
| Precio de compra | 9.96 |
| Capitalización de mercado | n/a |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | 8.58M |
| Beta | n/a |
| EPS (TTM) | n/a |
| Ratio PER (TTM) | n/a |
| Adelante PE | n/a |
| P/B (TTM) | -36.32 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | 10.12 |
| Volumen | 2,671 |
| Volumen medio (20D) | 546 |
| Abierto | 10.17 |
| Anterior Cerrar | 10.18 |
| Rango del día | 10.17 - 10.20 |
| Rango de 52 semanas | 9.94 - 10.80 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de DMIIU
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York...
Industria Shell Companies
Sector Financial Services
IPO Fecha Sep 25, 2025
Empleados n/a
Bolsa de Valores NasdaqGM
Símbolo bursátil DMIIU
Desempeño financiero
En 2025, los ingresos de Drugs Made In America Acquisition II fueron 0, un aumento de undefined% en comparación con n/a del año anterior. Las ganancias fueron 4.19M, un aumento de undefined%.
Estados financieros
